表紙
市場調査レポート

Molecular Templates Inc.の製品パイプライン分析

Molecular Templates Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 311249
出版日 ページ情報 英文 28 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
Molecular Templates Inc.の製品パイプライン分析 Molecular Templates Inc. - Product Pipeline Review - 2015
出版日: 2015年08月31日 ページ情報: 英文 28 Pages
概要

Molecular Templates Inc. は、免疫原性を抑制しPEG化を誘導するバイオ治療薬の開発を行っている製薬企業です。癌の治療薬分野において有望な臨床開発中の薬剤があり、メラノーマ細胞における未確認のレセプターに対応する化合物や、ETBという、抗毒素のスクリーニング可能なライブラリを作成しています。

当レポートでは、Molecular Templates Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Molecular Templates Inc.の基本情報

  • Molecular Templates Inc.の概要
  • 主要情報
  • 企業情報

Molecular Templates Inc.:R&Dの概要

  • 主な治療範囲

Molecular Templates Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Molecular Templates Inc.:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Molecular Templates Inc.:薬剤プロファイル

  • 5G-2
  • MT-2274
  • MT-3724
  • MT-4001
  • MT-4001V2
  • MT-4001V3
  • MT-4001V4
  • MT-4001V5
  • MT-4001V6
  • MTSAM-3

Molecular Templates Inc.:パイプライン分析

  • 標的別
  • 分子タイプ別
  • 作用機序別

Molecular Templates Inc.:最近のパイプライン動向

Molecular Templates Inc.:本社と子会社の所在地

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07421CDB

Summary

Global Markets Direct's, 'Molecular Templates Inc. - Product Pipeline Review - 2015', provides an overview of the Molecular Templates Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Molecular Templates Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Molecular Templates Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Molecular Templates Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Molecular Templates Inc.'s pipeline products

Reasons to buy

  • Evaluate Molecular Templates Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Molecular Templates Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Molecular Templates Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Molecular Templates Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Molecular Templates Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Molecular Templates Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Molecular Templates Inc. Snapshot
    • Molecular Templates Inc. Overview
    • Key Information
    • Key Facts
  • Molecular Templates Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Molecular Templates Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Molecular Templates Inc. - Pipeline Products Glance
    • Molecular Templates Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Molecular Templates Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Molecular Templates Inc. - Drug Profiles
    • MT-3724
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MT-2289
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MT-2H84ND
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MT-4019
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MT-4019NAS
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MT-4019ND
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Proteins for Melanoma and Hodgkin's Lymphoma
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Molecular Templates Inc. - Pipeline Analysis
    • Molecular Templates Inc. - Pipeline Products by Target
    • Molecular Templates Inc. - Pipeline Products by Molecule Type
    • Molecular Templates Inc. - Pipeline Products by Mechanism of Action
  • Molecular Templates Inc. - Recent Pipeline Updates
  • Molecular Templates Inc. - Dormant Projects
  • Molecular Templates Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Molecular Templates Inc., Key Information
  • Molecular Templates Inc., Key Facts
  • Molecular Templates Inc. - Pipeline by Indication, 2015
  • Molecular Templates Inc. - Pipeline by Stage of Development, 2015
  • Molecular Templates Inc. - Monotherapy Products in Pipeline, 2015
  • Molecular Templates Inc. - Phase I, 2015
  • Molecular Templates Inc. - Preclinical, 2015
  • Molecular Templates Inc. - Discovery, 2015
  • Molecular Templates Inc. - Pipeline by Target, 2015
  • Molecular Templates Inc. - Pipeline by Molecule Type, 2015
  • Molecular Templates Inc. - Pipeline Products by Mechanism of Action, 2015
  • Molecular Templates Inc. - Recent Pipeline Updates, 2015
  • Molecular Templates Inc. - Dormant Developmental Projects,2015

List of Figures

  • Molecular Templates Inc. - Pipeline by Top 10 Indication, 2015
  • Molecular Templates Inc. - Pipeline by Stage of Development, 2015
  • Molecular Templates Inc. - Monotherapy Products in Pipeline, 2015
  • Molecular Templates Inc. - Pipeline by Top 10 Target, 2015
  • Molecular Templates Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Molecular Templates Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top